77 af 109 (71%) patienter og 64 af 159 (40%) patienter HBV- DNA- niveauer, som ikke kunne påvises, ved uge 48 (< 1. 000 kopier/ ml Roche Amplicor Monitor PCR analysen).
In the pre-liver transplantation and post-liver transplantation cohorts 77 of 109 (71%) patients and 64 of 159 (40%) patients, respectively, achieved undetectable HBV DNA levels at week 48 (< 1,000 copies/ ml Roche Amplicor Monitor PCR assay).